AC Immune SA (ACIU)
2.47
-0.02 (0.80%)
Upcoming Events
Latest Headlines
Form 3/A AC Immune SA For: Oct 02 Filed by: Graney Thomas
October 9, 2026 5:22 PM - SEC Filing
Form 3 AC Immune SA For: Oct 02 Filed by: Graney Thomas
October 9, 2026 8:09 AM - SEC Filing
Form 6-K AC Immune SA For: Oct 02
October 2, 2026 8:02 AM - SEC Filing
H.C. Wainwright Reiterates Buy Rating on AC Immune SA (ACIU)
September 24, 2026 6:48 AM - StreetInsider
AC Immune reports positive Phase 2 results for Parkinson's vaccine ACI-7104
September 23, 2026 7:02 AM - StreetInsider
AC Immune Reports Positive Safety & Immunogenicity at week-100 in Part 1 of VacSYn Phase 2 Trial of ACI-7104
September 23, 2026 7:00 AM - Globe NewsWire
Form 6-K AC Immune SA For: Sep 23
September 23, 2026 7:00 AM - SEC Filing
AC Immune reports positive week-100 data for Parkinson's vaccine trial
September 23, 2026 7:00 AM - StreetInsider
AC Immune Reports Positive Safety & Immunogenicity at week-100 in Part 1 of VacSYn Phase 2 Trial of ACI-7104
September 23, 2026 7:00 AM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on AC Immune SA (ACIU)
August 24, 2026 6:55 AM - StreetInsider
Form 6-K AC Immune SA For: Aug 20
August 20, 2026 7:00 AM - SEC Filing
AC Immune reports early Phase 1 data for NLRP3 inhibitor ACI-19764
August 20, 2026 7:00 AM - StreetInsider
AC Immune Announces Positive Preliminary Phase 1 Data for NLRP3 Inhibitor ACI-19764
August 20, 2026 7:00 AM - StreetInsider
Form 6-K AC Immune SA For: Aug 11
August 11, 2026 7:00 AM - SEC Filing
AC Immune gets FDA fast track for Parkinson's drug ACI-7104
August 11, 2026 7:00 AM - StreetInsider
AC Immune Receives FDA Fast Track Designation for Anti-Alpha-synuclein Active Immunotherapy, ACI-7104, to Treat Early Parkinson’s Disease (PD)
August 11, 2026 7:00 AM - StreetInsider
Form 6-K AC Immune SA For: Jun 30
August 5, 2026 7:01 AM - SEC Filing
AC Immune First Half 2026 Financial and Corporate Update
August 5, 2026 7:00 AM - StreetInsider
Full Article List
